Capstone Investment Advisors, LLC Incyte Corp Put Options Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $71,652 - $89,250	1,400 Added 700.0%	1,600 $96,000
Q1 2024 May 01, 2024	SELL	$56.55 - $66.59 $118,755 - $139,839	-2,100 Reduced 91.3%	200 $11,000
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $573,760 - $706,090	-11,000 Reduced 82.71%	2,300 $144,000
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $300,404 - $342,836	-5,200 Reduced 28.11%	13,300 $768,000
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $18,285 - $22,653	-300 Reduced 1.6%	18,500 $1.15 Million
Q1 2023 May 09, 2023	SELL	$70.23 - $86.01 $1.3 Million - $1.59 Million	-18,500 Reduced 49.6%	18,800 $1.36 Million
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $208,258 - $260,741	3,100 Added 9.06%	37,300 $3 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $244,866 - $306,582	3,700 Added 12.13%	34,200 $2.28 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $3.92 Million - $4.93 Million	-59,300 Reduced 66.04%	30,500 $2.32 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $6.59 Million - $7.96 Million	-99,800 Reduced 52.64%	89,800 $7.13 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $1.6 Million - $1.87 Million	25,300 Added 15.4%	189,600 $13.9 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $501,291 - $613,346	7,300 Added 4.65%	164,300 $0
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $1.98 Million - $2.17 Million	24,800 Added 18.76%	157,000 $0
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $3.17 Million - $4.19 Million	41,700 Added 46.08%	132,200 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $2.18 Million - $2.64 Million	27,000 Added 42.52%	90,500 $7.87 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $2.14 Million - $2.75 Million	-25,100 Reduced 28.33%	63,500 $5.7 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $3.25 Million - $4.77 Million	43,800 Added 97.77%	88,600 $9.21 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.99 Million - $2.71 Million	-31,500 Reduced 41.28%	44,800 $3.28 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.24 Million - $1.63 Million	17,000 Added 28.67%	76,300 $6.66 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $480,611 - $571,032	6,600 Added 12.52%	59,300 $4.4 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $448,472 - $541,070	6,100 Added 13.09%	52,700 $4.48 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1.34 Million - $1.86 Million	21,100 Added 82.75%	46,600 $4.01 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $620,100 - $741,364	10,600 Added 71.14%	25,500 $1.62 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $920,075 - $1.11 Million	14,900 New	14,900 $1.03 Million

Others Institutions Holding INCY

# of Institutions

628

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account